Thursday, March 5, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Can you tell when your provider does not trust you?

Question asked:
“How strongly do you believe that you can tell when your provider does not trust you?”

Key findings (n = 246):

  • 77% of respondents report they can tell strongly or very strongly when a provider does not trust them.

  • Only 7% report little to no ability to detect distrust.

  • 17% remain unsure, suggesting ambiguity rather than neutrality.

Interpretation:
Perceived trust is not subtle for most patients. A large majority believe they can reliably sense when a clinician doubts their honesty, adherence, or intentions. This suggests that provider trust—or lack thereof—is experienced as an emotionally salient signal, not a background variable.

A. Implications for Patients

  1. Reduced Disclosure

    • Patients who sense distrust may withhold symptoms, medication nonadherence, or social factors.

    • This increases diagnostic error and undermines shared decision-making.

  2. Emotional Withdrawal

    • Perceived distrust activates shame and defensiveness, especially in chronic pain, mental health, obesity, and substance-use contexts.

    • Patients may disengage silently rather than confront the issue.

  3. Care Avoidance

    • Repeated experiences of distrust can lead patients to delay care, switch providers, or rely on non-clinical sources (online forums, influencers).


B. Implications for Physicians

  1. Unintentional Signaling

    • Micro-behaviors (tone, interruptions, chart-focused attention, skepticism framing) may communicate distrust even when none is intended.

    • These signals often operate below conscious awareness.

  2. Clinical Efficiency Paradox

    • Distrust may feel time-saving (“cutting through the story”), but it often costs time later through repeated visits, nonadherence, and conflict.

  3. Burnout Feedback Loop

    • Distrust erodes relational satisfaction for clinicians, increasing emotional exhaustion and reinforcing cynical practice patterns.


C. System-Level Insight

  • Trust should be treated as a measurable clinical variable, not a “soft skill.”

  • Surveys like this can inform:

    • clinician training

    • patient-experience metrics

    • value-based care incentives

    • AI-assisted documentation and communication tools

 

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

2027 Medicare Advantage & Part D Advance Notice

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!